Who invested in Lyra Therapeutics

One round we have observed, with the 6 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$30Mraised across 1 round since 2018, from 1 source

Latest round: Series B, $30MSept 2018
Investors: 6

See who backed them

The rounds

Sept 2018
Series B$30M
- Intersouth Partners
- Goldbell Group
- ArrowMark Partners
- NORTHBRIDGE EQUITY
- Soleus Capital
- Perceptive Advisors/ RA Capital
Reported by FinSMEs

Founders and team

From Lyra Therapeutics's own website and the SEC filings it signed: 8 on the team.

Allison NanceSenior Vice President of Regulatory Affairs
Jim TobinLead Independent Director
Harlan WaksalExecutive Officer, Directori
Jason CavalierExecutive Officeri
John R. BishopExecutive Officeri
Maria PalasisExecutive Officer, Directori
Richard R. NiemanExecutive Officeri
W. Bradford SmithBoard Director

On the board, as filediEdward AndersonJames R. TobinKonstantin Ann PoukalovMichael AltmanNancy Bradford Snyderman

AdvisersC. Ann Merrifield

Everyone who backed them

Intersouth PartnersVC firm1round

Goldbell GroupGrowth equity1round

ArrowMark PartnersPrivate equity1round

NORTHBRIDGE EQUITYPrivate equity1round

Soleus CapitalPrivate equity1round

Perceptive Advisors/ RA Capitalno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Lyra Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Longview VenturesVC firmPer its own site

Quick answers about Lyra Therapeutics

Who invested in Lyra Therapeutics?

Lyra Therapeutics's investors include Intersouth Partners, Goldbell Group, ArrowMark Partners, NORTHBRIDGE EQUITY and Soleus Capital, and 1 more on record.